Atlas FDA

Pipeline Flex Embolization Device

FDA premarket approval P100018/S022 · decided 2019-12-10

Approval details

PMA number
P100018
Supplement
S022
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Pipeline Flex Embolization Device
Generic name
Intracranial aneurysm flow diverter
Applicant
Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
Date received
2019-08-21
Decision date
2019-12-10
Days to decision
111 days
Decision code
APPR
Product code
OUT
Advisory committee
Neurology
Expedited review
No
Location
Irvine, CA
Statement
Approval for a manufacturing site located at Medtronic Distribution Center, 4340 Swinnea Road, Memphis, Tennessee 38118 for the repackaging of the Apollo Onyx Delivery Micro Catheter and Pipeline Flex Embolization Device.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Rist 079 Radial Access Guide Catheter; Rist 071 Radial Access Guide Catheter; Rist Radial Access Selective Catheter (K241388)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2025-01-02
Riptide™ Aspiration Pump; Riptide™ Collection Canister with Intermediate Tubing (K243418)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2024-12-02
Riptide Aspiration System (K243080)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2024-10-29
Rist 071 Radial Access Guide Catheter (K211990)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2021-07-27
Axium Detachable Coil; Axium Prime Detachable Coil (K203432)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2021-07-07
Solitaire X Revascularization Device (K203358)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2021-03-01
Concerto Versa, Detachable Coil (K202850)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2021-02-09
Solitaire Platinum Revascularization Device, Solitaire X Revascularization Device (Solitaire Revascularization Device) (K193576)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2020-11-20